These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 26156887

  • 1. Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan.
    Chella N, Daravath B, Kumar D, Tadikonda RR.
    Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):517-26. PubMed ID: 26156887
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: In vitro-in silico approach.
    Medarević D, Cvijić S, Dobričić V, Mitrić M, Djuriš J, Ibrić S.
    Eur J Pharm Sci; 2018 Nov 01; 124():188-198. PubMed ID: 30144529
    [Abstract] [Full Text] [Related]

  • 5. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S, Yue S, Huang Q, Wang W, Yang J, Lan K, Ye L.
    Eur J Drug Metab Pharmacokinet; 2016 Aug 01; 41(4):413-22. PubMed ID: 25669445
    [Abstract] [Full Text] [Related]

  • 6. Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers.
    Xu WJ, Xie HJ, Cao QR, Shi LL, Cao Y, Zhu XY, Cui JH.
    Drug Deliv; 2016 Aug 01; 23(1):41-8. PubMed ID: 24735247
    [Abstract] [Full Text] [Related]

  • 7. Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.
    Metre S, Mukesh S, Samal SK, Chand M, Sangamwar AT.
    Mol Pharm; 2018 Feb 05; 15(2):652-668. PubMed ID: 29287144
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Design of a novel type IV lipid-based delivery system for improved delivery of drugs with low partition coefficient.
    Narayana L, Chella N, Kumar D, Shastri NR.
    J Liposome Res; 2015 Feb 05; 25(4):325-33. PubMed ID: 25776099
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Improved pH-independent dissolution and oral absorption of valsartan via the preparation of solid dispersion.
    Park YJ, Lee HK, Im YB, Lee W, Han HK.
    Arch Pharm Res; 2010 Aug 05; 33(8):1235-40. PubMed ID: 20803127
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.
    Onoue S, Kojo Y, Aoki Y, Kawabata Y, Yamauchi Y, Yamada S.
    Drug Metab Pharmacokinet; 2012 Aug 05; 27(4):379-87. PubMed ID: 22240843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.